MMP-9 secreted by M2-type macrophages promotes Wilms' tumour metastasis through the PI3K/AKT pathway

Kaixuan Tian1,2, Guoqiang Du2, Xiaoqing Wang2

  • 1Department of Pediatric Orthopaedics, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, Hebei, People's Republic of China.

Molecular Biology Reports
|February 2, 2022
PubMed
Abstract

Insights

M2 macrophages promote Wilms' tumour growth and spread by releasing MMP9, which drives epithelial-mesenchymal transition via the PI3K/AKT pathway. High MMP9 levels in tumour tissue indicate a poor prognosis for childhood cancer patients.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Wilms' tumour (WT) is a common childhood kidney cancer.
  • Tumour-associated macrophages (TAMs) are linked to poor prognosis in WT, but their exact role is unclear.
  • Understanding TAMs' protumorigenic mechanisms is crucial for improving WT treatment.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which TAMs promote Wilms' tumour progression.
  • To investigate the role of Matrix metalloproteinase 9 (MMP9) in TAM-mediated WT growth and metastasis.

Main Methods:

  • Polarization of TAMs into M1 and M2 subtypes and co-culture with WT cells.
  • Assessment of cell viability, invasion, and MMP9 expression.
  • Analysis of MMP9 distribution in WT tissues and correlation with patient survival data.

Main Results:

  • M2 macrophages significantly enhanced WT cell viability and invasion compared to M1 macrophages.
  • M2 macrophages exhibited higher MMP9 expression, which was elevated in WT tissues.
  • MMP9 activated the PI3K/AKT pathway, promoting epithelial-mesenchymal transition (EMT), proliferation, and invasion in WT.
  • High MMP9 expression correlated with poor patient survival.

Conclusions:

  • M2-type TAMs promote Wilms' tumour proliferation and metastasis.
  • This occurs via MMP9 secretion, which enhances EMT through the PI3K/AKT pathway.
  • MMP9 serves as a potential biomarker for poor prognosis in Wilms' tumour.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K